Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:04 AM
Ignite Modification Date:
2025-12-25 @ 5:04 AM
NCT ID:
NCT04179318
Eligibility Criteria:
Inclusion Criteria:
* The patients were diagnosed with invasive breast cancer with positive hormone receptor (including positive estrogen receptor or progesterone receptor) and negative human epidermal growth factor receptor 2 (HER2)
* Axillary lymph node assessment : pN0 or PN1
* Women aged 18 and over
* Patients without chemotherapy after operation
Exclusion Criteria:
* Patients with negative hormone receptor （both estrogen and progesterone receptor are negative）
* Human epidermal growth factor receptor 2 （HER2） positive
* Pathological nodule evaluation: pN2 or pN3
* Male patients
* Patients receiving chemotherapy after surgery
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT04179318
Study Brief:
Protocol Section:
NCT04179318